Chordate Medical Valuation
| CMH Stock | 18.05 0.80 4.24% |
At this time, the firm appears to be overvalued. Chordate Medical Holding shows a prevailing Real Value of USD15.34 per share. The current price of the firm is USD18.05. Our model approximates the value of Chordate Medical Holding from analyzing the firm fundamentals such as Shares Outstanding of 157.71 M, return on equity of -1.68, and Operating Margin of (54.40) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Chordate Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Chordate Medical Holding is based on 3 months time horizon. Increasing Chordate Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Chordate Medical's intrinsic value may or may not be the same as its current market price of 18.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.05 | Real 15.34 | Hype 18.05 | Naive 18.29 |
The intrinsic value of Chordate Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chordate Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Chordate Medical Holding helps investors to forecast how Chordate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chordate Medical more accurately as focusing exclusively on Chordate Medical's fundamentals will not take into account other important factors: Chordate Medical Total Value Analysis
Chordate Medical Holding is currently forecasted to have takeover price of 102.78 M with market capitalization of 80.99 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chordate Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
102.78 M | 80.99 M |
Chordate Medical Investor Information
About 40.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Chordate Medical Holding had not issued any dividends in recent years. The entity had 500:1 split on the 29th of August 2024. Chordate Medical Holding is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Chordate Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chordate Medical has an asset utilization ratio of 1.98 percent. This implies that the Company is making USD0.0198 for each dollar of assets. An increasing asset utilization means that Chordate Medical Holding is more efficient with each dollar of assets it utilizes for everyday operations.Chordate Medical Ownership Allocation
Chordate Medical holds a total of 157.71 Million outstanding shares. Chordate Medical Holding retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chordate Medical Profitability Analysis
The company reported the revenue of 618.01 K. Net Loss for the year was (19.76 M) with profit before overhead, payroll, taxes, and interest of 1.93 M.About Chordate Medical Valuation
The stock valuation mechanism determines Chordate Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Chordate Medical Holding based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chordate Medical. We calculate exposure to Chordate Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chordate Medical's related companies.8 Steps to conduct Chordate Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Chordate Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Chordate Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Chordate Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Chordate Medical's revenue streams: Identify Chordate Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Chordate Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Chordate Medical's growth potential: Evaluate Chordate Medical's management, business model, and growth potential.
- Determine Chordate Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Chordate Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.